• Datametrex (DM) has announced a new milestone with its Medi-Call telehealth business
  • Medi-Call will begin to take live telehealth patient requests via the mobile application beginning on May 24, 2022
  • The company is also announcing that Andrew Ryu has stepped down as Director and Executive Chairman with Director Paul Haber taking his place
  • Datametrex develops AI-powered solutions for cyber security, telehealth and electric vehicles
  • Datametrex (DM) is down by 3.23 per cent trading at $0.15 per share

Datametrex (DM) has announced a new milestone with its Medi-Call telehealth business.

Medi-Call will begin to take live telehealth patient requests via the mobile application beginning on May 24, 2022.

Medi-Call is a subscription-based mobile app that connects patients with doctors in real time.

It increases medical accessibility for patients with limited mobility or who live in rural or isolated communities.

“We are excited with the progress we’ve made with Medi-Call and cannot wait to begin bringing it to more patients in need of direct health care, both in person and through telemedicine,” said Omar Sharif, President of Medi-Call.

The company is also announcing that Andrew Ryu has stepped down as Director and Executive Chairman for personal reasons. Director Paul Haber has been appointed in his place.

Datametrex develops AI-powered solutions for cyber security, telehealth and electric vehicles.

Datametrex (DM) is down by 3.23 per cent trading at $0.15 per share as of 10:06 am EST.

More From The Market Online

SPARC AI closer to showing its tech to defence customers

Technology company SPARC AI Inc. (CSE:SPAI) successfully completes testing its SPARC AI geospatial application at 100 km per hour.

Major U.S. airport purchases Liberty Defense’s HEXWAVE product

Liberty Defense Holdings (TSXV:SCAN) announces its HEXWAVE screening product was purchased by a major international airport in New York.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.

Shopify and Avalara expand partnership

Shopify (TSX:SHOP) expands its partnership with Avalara, a provider of cloud-based tax compliance automation for businesses.